J.B. Chemicals & Pharmaceuticals Lt (Delisted) share news and announcements
BSE: 506943Pharmaceuticals & Biotechnology
Last traded ₹2,408.90 on 16 Jul 2026
Delisted on 12 Oct 2026.
J.B. Chemicals & Pharmaceuticals Lt share news and announcements
1,922 announcements, routine notices left out, newest first. Page 38 of 39.
Jun 2009
15 Jun · Meeting
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Annual General Meeting of the Shareholders of the Company will be held on July 13, 2009.
May 2009
15 May · Updates
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange brief details of Annual Accounts for the year ended on March 31, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.14 May · Corporate action
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Register of Members and the Share Transfer Books will remain closed from July 04, 2009 to July 13, 2009 (both days inclusive) for the purpose of Annual General Meeting and Declaration of Dividend.13 May · Business
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding press release with respect to audited financial results for the year ended on March 31, 2009. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 May · Dividend
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Board of Directors of the company at its meting held on May 12, 2009 has recommended dividend @ Re.1.00 (50%) per equity share of face value of Rs 2/- for the financial year ended 2008-09. This together with dividend tax would absorb Rs. 986.58 lacs.
Apr 2009
27 Apr · Board meeting
To consider and approve annual audited financial results for the year ended on March 31, 2009. Further, the board of directors at the above referred meeting would also consider recommendation of dividend for the year 2008-09.9 Apr · Results
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Company opts to submit to the Exchange audited financial resulta for the entire financial year ended on March 31, 2009. Therefore the Company will not submit unaudited financial results for the last quarter ended on March 31, 2009.
Feb 2009
10 Feb · Disclosure
Jb Chemicals & Pharmaceuticals Ltd. had informed the Exchange that a person forming part of the Promoter Group of the Company has pledged 38,000 equity shares (face value Rs. 2) of the company. The shares pledged represent 0.04% of the equity share capital of the Company. The Company has now informed the Exchange that, the company has been informed by Mr. Bharat P. Mehta, a person forming part of the Promoter Group, holding 251525 equity shares (face value Rs.2/-) of the company that the pledge on the aforesaid 38,000 equity shares has been released. The said 38,000 equity shares were pledged by him prior to January 28, 2009 i.e. the date of notification of the SEBI (SAST) (Amendment) Regulations, 2009. The shares pledged represented 15.11% of the total shares held by Mr. Bharat P. Mehta in the Company and 0.04% of the total number of outstanding shares of the Company. Further, the Company has informed that now no share in the company held by the promoter/persons forming part of the Promoter Group is under pledge.4 Feb · Disclosure
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that "Based on the disclosure received pursuant to Regulation 8A(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, this is to inform you that a person forming part of the Promoter Group of the Company has pledged 38,000 equity shares (face value Rs. 2) of the company. The shares pledged represent 0.04% of the equity share capital of the Company. We have also been informed that steps have been taken for release of the said pledged shares and such release is expected this month".
Jan 2009
23 Jan · Business
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding press release on unaudited financial results for the quarter / nine months ended on December 31, 2008. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Jan · Disclosure
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of the list giving details of shares held by directors and employees (together with relatives) of the Company as on December 31, 2008, in compliance with the Code of Conduct for Prevention of Insider Trading framed by the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Jan · Board meeting
Meeting on 22 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Dec 2008
12 Dec · Disclosure
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that Mr. B. P. Mehta one of the promoters of the Company has informed the company vide letter dated December 09, 2008 that he has acquired 13,000 equity shares of the Company through open market purchase in normal segment on the National Stock Exchange of India Limited. This purchase represents 0.01% of the equity share capital of the Company. With the aforesaid purchase of 13,000 shares, Mr. B. P. Mehta, his aggregate shareholding in the Company has gone up to 2,36,525 equity shares, which represents 0.28% of the equity share capital of the Company.1 Dec · Disclosure
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that "Unique Pharmaceutical Laboratories Ltd. is one of the promoters of ("Target Company") and has informed the company vide letter dated December 01, 2008 that it has acquired 25000 equity shares of the Target Company through open market purchase in normal segment on the Bombay Stock Exchange Ltd. Prior to the above referred information from the said promoter, Unique Pharmaceutical Laboratories Limited held 4457390 equity shares of Rs.2/- representing 5.28% of the equity share capital of the company. After the said purchase of 25000 equity shares, Unique Pharmaceutical Laboratories Limited's aggregate shareholding in the Target Company has gone up to 4482390 equity shares that represents 5.31% equity share capital of the Target Company".1 Dec · Disclosure
Unique Pharmaceutical Laboratories Ltd. has informed the Exchange that "Unique Pharmaceutical Laboratories Ltd. is one of the promoters of J B Chemicals & Pharmaceuticals Limited ("Target Company") and holds 44,57,390 equity shares of Rs.2/- each (5.28%) of the Target Company, prior to this disclosure. Further on November 26, 2008, the company has purchased 25,000 equity shares of the Target Company through open market purchase in normal segment on the Bombay Stock Exchange Ltd; After the said purchase 25,000 shares, the total shareholding of the company in the Target Company has gone up to 44,82,390 equity shares that represent 5.31% of the equity shares capital of the Target Company".
Nov 2008
28 Nov · Disclosure
Unique Pharmaceutical Laboratories Ltd. has informed the Exchange that "Unique Pharmaceutical Laboratories Ltd. is one of the promoters of J B Chemicals & Pharmaceuticals Limited ("Target Company") and holds 44,32,390 equity shares of Rs.2/- each (5.26%) of the Target Company, prior to this disclosure.Further on November 25, 2008, the company has purchased;(i) 23,863 equity shares of the Target Company through open market purchase in normal segment on the Bombay Stock Exchange Ltd; and(ii) 1,137 equity shares of the Target Company through open market purchase in normal segment on the National Stock Exchange of India Ltd.The aggregate number of shares purchased amounts to 25,000 that represent 0.02% of the equity share capital of the Target Company. After the said purchase 25,000 shares, the total shareholding of the company in the Target Company has gone up to 44,57,390 equity shares that represent 5.28% of the equity shares capital of the Target Company".28 Nov · Disclosure
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that: "Unique Pharmaceutical Laboratories Limited is one of the promoters of the company and has informed the company vide letter dated November 28, 2008 that it has acquired:(i) 23,863 equity shares of the company through open market purchase in normal segment on the Bombay Stock Exchange Ltd; and(ii) 1,137 equity shares of the company through open market purchase in normal segment on the National Stock Exchange Ltd. Thus, the said promoter of the company has acquired 25,000 equity shares of the company from open market in a normal segment on the BSE and NSE. Prior to the above referred information from the said promoter, Unique Pharmaceutical Laboratories Limited held 44,32,390 equity shares of Rs.2/- each amounting 5.26% of the equity share capital of the company. After the said purchase of 25,000 equity shares, Unique Pharmaceutical Laboratories Limited's aggregate shareholding in the company has gone up to 44,57,390 equity shares that represent 5.28% equity share capital of the Company".5 Nov · Updates
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of the Chairman's Letter to the Shareholders dated October 27, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
22 Oct · Business
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated October 20, 2008, with respect to Unaudited Financial Results of the Company for the second quarter/half-year ended September 30, 2008. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Oct · Management
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Board of Directors has appointed Mr. Mayur Mehta as Compliance Officer. The details of the Compliance Officer are as follows: Mr. Mayur Mehta, Company Secretary - General Manager; Email Id: [email protected]13 Oct · Disclosure
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of the list giving details of shares held by directors and employees (together with relatives) of the Company as on September 30, 2008, in compliance with Regulation 13 (3) and 13 (4) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 1992 and the Code of Conduct for Prevention of Insider Trading prescribed by the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Oct · Board meeting
To consider and to take on record the Unaudited Financial Results of the Company for the quarter/half year ended on September 30, 2008.
Jul 2008
29 Jul · Meeting
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of the minutes of the Annual General Meeting of the Company held on July 18, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.28 Jul · Business
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated July 25, 2008, with respect to Unaudited Financial Results of the Company for the quarter ended June 30, 2008. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Jul · Updates
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of a Chairman's Speech delivered by Shri J. B. Mody, Chairman & Managing Director of the Company at the Annual General Meeting of the Company held on July 18, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Jul · Meeting
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Annual General Meeting of the Company was held on July 18, 2008 where all the business listed in the Notice was transacted and the resolutions for the same were passed unanimously by the Members except item no. 1,8,9,10,11,12,13 & 14 which were passed with requisite majority. The members of the Company approved declaration of Dividend @ 25% i.e. Rs.0.50/- per Equity share of Rs.2/- each. The date of payment of dividend will be July 25, 2008. Further a copy of the notice of AGM shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Jul · Board meeting
Meeting on 25 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”14 Jul · Disclosure
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of the list giving details of shares held by promoters and employees (together with relatives) of the Company as on June 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Jul · Board meeting
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange vide its letter dated July 04, 2008 that "The Board of Directors of the Company at their meeting held today reviewed the progress and implementation of buy back of equity shares. Based on the report and consensual views of the Share Buy-back Committee, the Board has decided and approved in the larger interest of both the Company and its shareholders in their entirety the following: (1) That the proposal for buy-back as mooted at the Board Meeting held on 8th April, 2008, be abandoned for the time being. (2). That in any event no further step or action or initiative be taken until well after the results of Q-1 for the current year 2008-09 have been considered by the Board of Directors and published so that, if any action in carrying forward the foregoing proposal is to be undertaken, the Shareholders are aware of the performance of the company for Q-1 of the current year 2008-09".4 Jul · Management
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that Mr. Beejal Desai, Vice-President & Company Secretary, has resigned from the services of the Company w.e.f. the close of business hours on June 30, 2008, and Ms. Jenny Dsouza- Asst. Company Secretary of the Company has been appointed as the Compliance Officer of the Company.
Jun 2008
27 Jun · Board meeting
At its Board Meeting held on April 8, 2008, the Board had approved, in principle, a Buy-Back of the Company's own shares up to the limit specified therein and providing for the ceiling rate at which such Buy-Back may be made. Following the reported view expressed by Securities & Exchange Board of India to the effect that even a Buy-Back by the Company can result in an increase in the Promoters' interest only if the same is exempted under the Take-over Code, the Special Committee appointed by the Board for the purpose of Buy-Back initiated steps to seek such exemption which process, however, is still not complete. In the meantime, having regard to the lapse of almost 3 months as also to the very material changes that have taken place in the Equity Markets in India, the Board has been advised to convene a meeting of the Special Committee and following that meeting, a meeting of the Board of Directors to review the situation in all aspects with a view to ensuring that the basic objective of the Buy-Back, namely, to enhance the shareholder value, is achieved. Accordingly, a meeting of the Special Committee has been convened on July 4, 2008 at 10.00 a.m. and a meeting of the Board of Directors is to be held at 11.30 am (or as soon as the meeting of the Special Committee is concluded if it goes beyond 11:30 a.m.) to review the matter.25 Jun · Meeting
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Annual General Meeting of the Company will be held on July 18, 2008.
May 2008
28 May · Updates
Jb Chemicals & Pharmaceuticals Ltd. had informed the Exchange that "This is with reference to the decision of the Board of Directors of the Company taken at its meeting held on April 8, 2008, approving a proposal for buy back of equity shares of the Company, a copy of which was filed with the Stock Exchanges vide its letter no. STOCKEXCHANGE\VP:MK\124, dated April 8, 2008 and the Public Notice published in the news papers on April 10, 2008 in compliance with the applicable Regulation(s) of the SEBI (Buy Back of Securities) Regulations 1998 thereafter". The Company has now informed the Exchange that "In this connection, as advised by the Merchant Banker M/s. PL Capital Markets Pvt. Ltd., the Company has filed an application under Regulation 4 of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations. 1997, (hereinafter called "takeover regulations") with SEBI on 26th May, 2008. seeking exemption from the applicability of Regulations 11 and 12 & such other applicable regulations of the takeover regulations in relation to any increase (if any) in the percentage shareholding of the promoters beyond the present shareholding of 55.50% of the paid-up Equity Share Capital of the Company consequent to the proposed Buy Back of Equity shares of the Company".15 May · Business
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange vide its letter dated May 14, 2008 regarding a press release dated May 08, 2008, titled "J.B. Chemicals & Pharmaceuticals Limited Announces Audited Financial Results for FY 2007-08; Recommends 25% Dividend". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 May · Dividend
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on May 08, 2008 have recommended Dividend @ Re. 0.50 (25%) per Equity Share, on 8,43,26,350 equity shares of Rs.2/- each, for the financial year ended 2007-08. Further the Register of Members and Share Transfer Books will remain closed from July 05, 2008 to July 18, 2008 (both days inclusive) for the purpose of payment of Dividend for the Financial Year ended 2007-08.
Apr 2008
28 Apr · Board meeting
To consider the draft Balance Sheet and Profit & Loss Account for the year ended March 31, 2008 and to recommend the payment of Dividend for the year ended 2007-2008. The dates for the purpose of book closure of Register of Members of the Company will also be considered in the same meeting.17 Apr · Disclosure
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of the list giving details of shares held by promoters and employees (together with relatives) of the Company as on March 31, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Apr · Management
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that "Dr. Rajen D. Shah, Director of the Company ceased to a Whole-time Director (Research & Development) w.e.f. April 1, 2008. However, he will continue on the Board of the Company as a Non Executive Director."10 Apr · Business
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated April 08, 2008, titled "J.B. Chemicals & Pharmaceuticals Limited Board approves Share Buyback at a maximum price of Rs.70/- per share". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Apr · Buyback of Shares
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a certified true copy of the resolution passed by the Board of Directors of the Company at their meeting held on April 08, 2008, approving the buy back from open market through Stock Exchanges, of fully paid equity shares of the Company at a price not exceeding Rs. 70/- per share for a total amount not exceeding Rs. 29.52 crores being 7.05% of the total paid up equity capital and free reserves of the Company as on 31st March, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.8 Apr · Buyback of Shares
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange vide its letter dated April 08, 2008 that : "The Board of Directors of the Company at their meeting held today considered and approved, subject to such other approvals/consents, as maybe necessary, the buyback of equity shares at a maximum price not exceeding Rs. 70/- per share and up to an aggregate amount of Rs. 29.52 crores, being within 7.05% of the total paid-up capital and free reserves as per the audited Balance Sheet as at 31st March 2007. The Company proposes to buy back shares listed on the Bombay Stock Exchange Limited ("BSE") and National Stock Exchange of India Limited ("NSE") through open market purchases from time to time. The Maximum price is at a premium of 41.27% over the closing price of Rs. 49.55/- of the Company's share on NSE as on 7th April, 2008. The average closing price of the Company's share on the BSE for the last six months is Rs. 64/-".7 Apr · Results
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that : "We will be publishing our audited financial result for the financial year ended March 31, 2008 before the end of June, 2008 and therefore we will not be publishing our fourth quarter un-audited results for the period ended on 31st March, 2008".
Mar 2008
26 Mar · Board meeting
To consider buy back of equity shares of the Company.
Jan 2008
30 Jan · Business
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated January 29, 2008, titled "J.B. Chemicals & Pharmaceuticals Limited announces Unaudited Financial Results for the third quarter ended 31st December, 2007". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jan · Board meeting
Meeting on 29 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”9 Jan · Business
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated January 09, 2008, titled "JBCPL receives EU GMP Approval". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Jan · Disclosure
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of the list giving details of shares held by promoters and employees (together with relatives) of the Company as on December 31, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2007
6 Nov · Business
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a Press Release dated October 30, 2007 titled as "J. B. Chemicals & Pharmaceuticals Limited Announces Unaudited Financial Results for the second quarter ended September 30, 2007". A copy of the Press Release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
18 Oct · Board meeting
Meeting on 30 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”11 Oct · Disclosure
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of the list giving details of shares held by promoters and employees (together with relatives) of the Company as on September 30, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.